Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACB Cardiac Marker May Receive Same Reimbursement Rate As BNP – Root

This article was originally published in The Gray Sheet

Executive Summary

A modified albumin point-of-care test for ruling out heart attacks likely will receive similar reimbursement to the $47 rate for B-type natriuretic peptide tests, according to Charles Root, president of consulting firm MCF Compliance

You may also be interested in...



Vysis Urges Pathvysion Lab Codes To Be Paid Under Physician Fee Schedule

CMS should map the new flow cytometry and surgical pathology CPT codes to the physician fee schedule, rather than the clinical laboratory fee schedule, according to Abbott/Vysis and AdvaMed

Vysis Urges Pathvysion Lab Codes To Be Paid Under Physician Fee Schedule

CMS should map the new flow cytometry and surgical pathology CPT codes to the physician fee schedule, rather than the clinical laboratory fee schedule, according to Abbott/Vysis and AdvaMed

Cross-Walking Urged For Six Lab Test Codes By Laboratory Societies

Lab associations' endorsement of the "cross-walking" mechanism to set payment rates for six new clinical lab test codes signifies industry-wide skepticism of "gap-filling" as a viable alternative, according to AdvaMed

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018064

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel